Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human LMOD1 ELISA Kit (AC2581)
Cat.#: ASET-1170
Specifications
Description Human LMOD1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human LMOD1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.041 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.25-20 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1161 Human SYNGR4 ELISA Kit (AC2572) Quantitative inquiry ASET-1638 Porcine TIMP3 ELISA Kit (AC3049) Quantitative inquiry ASET-1717 Mouse DLL4 ELISA Kit (AC3128) Quantitative inquiry ASET-1232 Human NENF ELISA Kit (AC2643) Quantitative inquiry ASET-1999 Chicken Neuropeptide Y ELISA Kit (AC3410) Quantitative inquiry ASET-2319 Human 5HT7 Receptor ELISA Kit (AC3730) Quantitative inquiry ASET-2368 Human Somatostatin ELISA Kit (AC3779) Quantitative inquiry ASET-2199 Mouse Ghrelin ELISA Kit (AC3610) Quantitative inquiry ASET-1654 Rat CDK5 ELISA Kit (AC3065) Quantitative inquiry ASET-1514 Human Slit3 ELISA Kit (AC2925) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket